PharmacyCodes



ANTIBIOTIC BL-P1322 en es it fr

ANTIBIOTIC BL-P1322 Brand names, ANTIBIOTIC BL-P1322 Analogs

ANTIBIOTIC BL-P1322 Brand Names Mixture

  • Isotamine B 300 (Isoniazid + Pyridoxine Hydrochloride)
  • Rifater (Isoniazid + Pyrazinamide + Rifampin)

ANTIBIOTIC BL-P1322 Chemical_Formula

C17H17N3O6S2

ANTIBIOTIC BL-P1322 RX_link

No information avaliable

ANTIBIOTIC BL-P1322 fda sheet

ANTIBIOTIC BL-P1322 msds (material safety sheet)

ANTIBIOTIC_BL-P1322 MSDS

ANTIBIOTIC BL-P1322 Synthesis Reference

No information avaliable

ANTIBIOTIC BL-P1322 Molecular Weight

423.466 g/mol

ANTIBIOTIC BL-P1322 Melting Point

No information avaliable

ANTIBIOTIC BL-P1322 H2O Solubility

1030 mg/L

ANTIBIOTIC BL-P1322 State

Solid

ANTIBIOTIC BL-P1322 LogP

-0.251

ANTIBIOTIC BL-P1322 Dosage Forms

Gel; Suspension

ANTIBIOTIC BL-P1322 Indication

For treatment of infections caused by susceptible bacteria.

ANTIBIOTIC BL-P1322 Pharmacology

Cephapirin is a first-generation cephalosporin that has a wide spectrum of activity against gram-positive and gram-negative organisms. Cephapirin is more resistant to beta-lactamases than are the penicillins and so is effective against staphylococci, with the exception of methicillin-resistant staphylococci.

ANTIBIOTIC BL-P1322 Absorption

No information avaliable

ANTIBIOTIC BL-P1322 side effects and Toxicity

Rats exposed via the oral route to cephapirin displayed low acute toxicity (LD50 = 14000 mg/kg). The most common adverse reactions are hypersensitivity reactions and alterations to liver function. Evidence of white blood cell disorders and anaemia were noted in some subjects.

ANTIBIOTIC BL-P1322 Patient Information

No information avaliable

ANTIBIOTIC BL-P1322 Organisms Affected

Enteric bacteria and other eubacteria